1. Cottin V, et al. Eur Respir Rev 2018;27:180076
2. Richeldi L, et al. Eur Respir Rev 2018;27:180074

The authors meet criteria for authorship as recommended by the International Committee of Medical Journal Editors (ICMJE). The authors would like to acknowledge Michael A. Kadoch for his contribution to discussions, as a member of the steering committee. The authors received no direct compensation related to the development of the poster. Writing support for this poster was provided by Leon Newman, PhD, of GeoMed, an Ashfield company, part of UDG Healthcare, which was contracted and compensated by Boehringer Ingelheim Pharmaceuticals, Inc. (BIPI), for these services. BIPI was given the opportunity to review the poster for medical and scientific accuracy as well as intellectual property considerations.

GH reports receipt of honoraria from Genentech, Mitsubishi Chemical, Gerson Lehrman Group, Boehringer Ingelheim and Medna-LLC. JG reports no conflicts of interest. HL reports being an employee of Boehringer Ingelheim at the time of study; he is currently employed by Altavant Sciences. JK reports receipt of grants from the National Institute of Health, Doris Duke foundation and the Department of Defence; he also reports receipt of grants and personal fees from Boehringer Ingelheim, and non-financial support from Genentech. SP reports receiving personal fees as an expert advisor from Boehringer Ingelheim during and outside of the conduct of the study. IR did not report any conflicts of interest. YR reports receipt of personal fees from Boehringer Ingelheim, Genentech and Bioclinica. AW reports receipt of consultant fees from F. Hoffmann-La Roche Ltd and Boehringer Ingelheim.

CT, computed tomography; HRCT, high-resolution computed tomography; IIP, idiopathic interstitial pneumonia; ILA, interstitial lung abnormalities; ILD, interstitial lung disease; PFT, pulmonary function test; RA, rheumatoid arthritis; SSc, systemic sclerosis.